Výsledky vyhledávání - "Debbie L. Becker"

Akademický článek

The Costs and Consequences of Methicillin-Resistant Staphylococcus aureus Infection Treatments in Canada

Autor: Andrew J Rosner, Debbie L Becker, Angelina H Wong, Elizabeth Miller, John M Conly

Publikováno v: Canadian Journal of Infectious Diseases and Medical Microbiology, Vol 15, Iss 4, Pp 213-220 (2004)

BACKGROUND: A multinational randomized controlled trial has shown a trend toward early discharge of patients taking oral linezolid versus intravenous vancomycin (IV) in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections. I

Externí odkaz: https://doaj.org/article/3116f921703b423c8bb8effaf3311e40

Zobrazit plný text záznamu

Akademický článek

A Retrospective Analysis of Practice Patterns in the Treatment of Methicillin-Resistant Staphylococcus aureus Skin and Soft Tissue Infections at Three Canadian Tertiary Care Centres

Autor: John M Conly, H Grant Stiver, Karl A Weiss, Debbie L Becker, Andrew J Rosner, Elizabeth Miller

Publikováno v: Canadian Journal of Infectious Diseases, Vol 14, Iss 6, Pp 315-321 (2003)

BACKGROUND: Methicillin-resistant Staphylococcus aureus (MRSA) infections are increasingly being encountered and pose an increasing burden to the health care system in Canada.

Externí odkaz: https://doaj.org/article/f167b1636baa4b7f846577d6a586d093

Zobrazit plný text záznamu

The potential public health and economic value of a hypothetical COVID-19 vaccine in the United States: Use of cost-effectiveness modeling to inform vaccination prioritization

Autor: Debbie L. Becker, Milton C. Weinstein, Michele A. Kohli, Michael Maschio

Publikováno v: Vaccine
Vaccine, 39(7):1157-1164

Background: Researchers are working at unprecedented speed to develop a SARS-CoV-2 vaccine. We aimed to assess the value of a hypothetical vaccine and its potential public health impact when prioritization is required due to supply constraints. Metho

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b2449d1fca71f5487ced53415ffc39a
https://pubmed.ncbi.nlm.nih.gov/33483216

Zobrazit plný text záznamu

High-Dose Inactivated Influenza Vaccine is Associated with Cost Savings and Better Outcomes Compared to Standard-Dose Inactivated Influenza Vaccine in Canadian Seniors

Autor: Carlos A. DiazGranados, Eddy Yau, Michael Drummond, Ayman Chit, Michael Maschio, Debbie L. Becker

Publikováno v: Human Vaccines & Immunotherapeutics

Seasonal influenza infects approximately 10–20% of Canadians each year, causing an estimated 12,200 hospitalizations and 3,500 deaths annually, mostly occurring in adults ≥65 years old (seniors). A 32,000-participant, randomized controlled clinic

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71b1c59a8173e09d164a15f40c8b41f2
https://eprints.whiterose.ac.uk/102626/2/DB_AC_CDG_MM_EY_MDF_HghDse_flu_vac_cst_savngs_Can_senors_Hum_Vacc_Immuno_aceptd_180716.pdf

Zobrazit plný text záznamu

Cost-Effectiveness of Maraviroc for Antiretroviral Treatment-Experienced HIV-infected Individuals in Mexico

Autor: Iris Contreras-Hernández, Gabriela Vega, Joaquin Mould-Quevedo, S. Marfatia, Jeremy Chancellor, Felicitas C. Kühne, Debbie L. Becker

Publikováno v: Value in Health. 13(8):903-914

Objective Maraviroc is the first approved drug in a new class of antiretrovirals, the CCR5 antagonists. The objective of this study was to predict the long-term clinical impact and cost-effectiveness of maraviroc in treatment-experienced adults with

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e8025bb659a942477b94d472f44b7ed

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání